**Core Concept**
Rho kinase (ROCK) inhibitors are a class of drugs that target the Rho-associated protein kinase, which plays a key role in various cellular processes including smooth muscle contraction, cell proliferation, and cytoskeletal organization. By inhibiting ROCK, these drugs can lead to vasodilation, reduced blood pressure, and potentially anti-inflammatory effects.

**Why the Correct Answer is Right**
The correct answer is a Rho kinase inhibitor because it selectively binds to and inhibits the Rho-associated protein kinase (ROCK), thereby preventing the downstream effects of RhoA activation. This leads to the relaxation of smooth muscle cells, decreased platelet activation, and reduced inflammation. The inhibition of ROCK also results in the prevention of the phosphorylation and activation of myosin light chain (MLC), which is essential for smooth muscle contraction.

**Why Each Wrong Option is Incorrect**
* **Option A:** This drug is actually a calcium channel blocker, which works by inhibiting the influx of calcium ions into smooth muscle cells, leading to vasodilation. It does not target the Rho kinase pathway.
* **Option B:** This drug is a phosphodiesterase inhibitor, which increases the levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in smooth muscle cells, leading to vasodilation. It does not inhibit Rho kinase.
* **Option D:** This drug is an endothelin receptor antagonist, which blocks the action of endothelin-1, a potent vasoconstrictor. It does not target the Rho kinase pathway.

**Clinical Pearl / High-Yield Fact**
Rho kinase inhibitors have been shown to have potential therapeutic benefits in various conditions, including hypertension, pulmonary arterial hypertension, and diabetic nephropathy. They may also have anti-inflammatory effects and could potentially be used in the treatment of fibrotic diseases.

**Correct Answer: C. Silodosin. Silodosin is a selective alpha-1A adrenergic receptor antagonist with Rho kinase inhibitory activity.**